Hydromorphone Hydrochloride Injection, Solution
Product Images NDC 0409-2634

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Hydromorphone Hydrochloride (NDC 0409-2634). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Hydromorphone 01)

Chemical structure of Hydromorphone Hydrochloride, showing the molecular arrangement of its atoms including hydroxyl, methyl, and ketone functional groups, along with the hydrochloride component.*

FDA Label Image

Logo (Hydromorphone 02)

FDA Label Image

Principal Display Panel (1 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection USP 10 mg/mL single-dose vial. The label indicates it is a high potency formulation (HPF), distributed by Hospira, Inc. in Lake Forest, IL. It includes a barcode and space for lot number and expiration date.*

FDA Label Image

Principal Display Panel (1 mL Vial Box)

Packaging label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL, high potency formulation (HPF) by Hospira, Inc. The carton contains 10 single-dose 1 mL vials. The label includes storage instructions, barcode, and controlled substance schedule II symbol. Distributed by Hospira, Inc., Lake Forest, IL, USA.*

FDA Label Image

Principal Display Panel (5 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection, USP 50 mg/5 mL (10 mg/mL) high potency formulation, in a 5 mL single-dose vial. The label indicates it is a Schedule II controlled substance for prescription use only. Distributed by Hospira, Inc., Lake Forest, IL, USA. NDC 0409-2634-25 is shown on the label.*

FDA Label Image

Principal Display Panel (5 mL Vial Box)

Packaging label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL in a high potency formulation. The package contains 10 single-dose vials of 5 mL each, for use in the preparation of large-volume parenteral solutions. Labeled for Rx only and distributed by Hospira, Inc.*

FDA Label Image

Principal Display Panel (50 mL Vial Label)

Label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL in a 50 mL single-dose vial. The high potency formulation (HPF) label indicates it is for prescription use. Manufactured by Hospira, Inc., the label includes storage instructions and a barcode.*

FDA Label Image

Principal Display Panel (50 mL Vial Box)

Packaging label for Hydromorphone Hydrochloride Injection, USP 10 mg/mL (500 mg/50 mL) high potency formulation by Hospira, Inc. The label indicates a single-dose vial with Rx only status, intended for use in the preparation of large-volume parenteral solutions. Storage and usage instructions are included, along with distributor information and barcodes.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.